Jungwon Yoon

Prof. Dr. Jungwon Yoon

Gwangju Institute of Science and Technology, School of Integrated Technology, Korea
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2022 in ACS Omega
Verified
Journal Article
Open access
YHYaser Hadadian
Yaser Hadadian
HMHajar Masoomi
Hajar Masoomi
ADAli Dinari
Ali Dinari
CRChiseon Ryu
Chiseon Ryu
SHSeong Hwang
Seong Hwang
JYJungwon Yoon
Jungwon Yoon
In this study, a comprehensive characterization of iron oxide nanoparticles synthesized by using a simple one-pot thermal decomposition route is presented. In order to obtain monodisperse magnetite nanoparticles with high saturation magnetization, close to the bulk material, the molar ratios between the starting materials (solvents, reducing agents, and surfactants) were varied. Two out of nine conditions investigated in this study resulted in monodisperse iron oxide nanoparticles with high saturation magnetization (90 and 93% of bulk magnetite). The X-ray diffraction analyses along with the inspection of the lattice structure through transmission electron micrographs revealed that the main cause of the reduced magnetization in the other seven samples is likely due to the presence of distortion and microstrain in the particles. Although the thermogravimetric analysis, Raman and Fourier transform infrared spectroscopies confirmed the presence of covalently bonded oleic acid on the surface of all the samples, the particles with higher polydispersity and the lowest surface coating molecules showed the lowest saturation magnetization. Based on the observed results, it could be speculated that the changes in the kinetics of the reactions, induced by varying the molar ratio of the starting chemicals, can lead to the production of the particles with higher polydispersity and/or lattice deformation in their crystal structures. Finally, it was concluded that the experimental conditions for obtaining high-quality iron oxide nanoparticles, particularly the molar ratios and the heating profile, should not be chosen independently; for any specific molar ratio, there may exist a specific heating profile or vice versa. Because this synthetic consideration has rarely been reported in the literature, our results can give insights into the design of iron oxide nanoparticles with high saturation magnetization for different applications.

16 August 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Mohamed S.A. DarwishMohamed S.A. Darwish
Mohamed S.A. Darwish
HKHoHyeon Kim
HoHyeon Kim
HLHwangjae Lee
Hwangjae Lee
CRChiseon Ryu
Chiseon Ryu
JLJae Young Lee
Jae Young Lee
JYJungwon Yoon
Jungwon Yoon
Magnetic nanoparticles (MNPs) that exhibit high specific loss power (SLP) at lower metal content are highly desirable for hyperthermia applications. The conventional co-precipitation process has been widely employed for the synthesis of magnetic nanoparticles. However, their hyperthermia performance is often insufficient, which is considered as the main challenge to the development of practicable cancer treatments. In particular, ferrite MNPs have unique properties, such as a strong magnetocrystalline anisotropy, high coercivity, and moderate saturation magnetization, however their hyperthermia performance needs to be further improved. In this study, cobalt ferrite (CoFe2O4) and zinc cobalt ferrite nanoparticles (ZnCoFe2O4) were prepared to achieve high SLP values by modifying the conventional co-precipitation method. Our modified method, which allows for precursor material compositions (molar ratio of Fe+3:Fe+2:Co+2/Zn+2 of 3:2:1), is a simple, environmentally friendly, and low temperature process carried out in air at a maximum temperature of 60 °C, without the need for oxidizing or coating agents. The particles produced were characterized using multiple techniques, such as X-ray diffraction (XRD), dynamic light scattering (DLS), transmission electron microscopy (TEM), ultraviolet-visible spectroscopy (UV–Vis spectroscopy), and a vibrating sample magnetometer (VSM). SLP values of the prepared nanoparticles were carefully evaluated as a function of time, magnetic field strength (30, 40, and 50 kA m−1), and the viscosity of the medium (water and glycerol), and compared to commercial magnetic nanoparticle materials under the same conditions. The cytotoxicity of the prepared nanoparticles by in vitro culture with NIH-3T3 fibroblasts exhibited good cytocompatibility up to 0.5 mg/mL. The safety limit of magnetic field parameters for SLP was tested. It did not exceed the 5 × 109 Am−1 s−1 threshold. A saturation temperature of 45 °C could be achieved. These nanoparticles, with minimal metal content, can ideally be used for in vivo hyperthermia applications, such as cancer treatments.

4 March 2010 in IEEE/ASME Transactions on Mechatronics
Verified
Journal Article
Closed access
JYJungwon Yoon
Jungwon Yoon
BNBondhan Novandy
Bondhan Novandy
CYChul-Ho Yoon
Chul-Ho Yoon
KPKi-Jong Park
Ki-Jong Park
This paper presents a 6-DOF gait rehabilitation robot that allows patients to update their walking velocity on various terrain types and navigate in virtual environments (VEs) through upper and lower limb connections. This robot is composed of an upper limb device, a sliding device, two footpad devices, and a body support system. The footpad device on the sliding device generates 3-DOF spatial motions on the sagittal plane for each foot. This allows the generation of various terrain types for diverse walking training. The upper limb device allows users to swing their arms naturally through the use of a simple pendulum link with a passive prismatic joint. Synchronized gait patterns for this robot are designed to represent a normal gait with upper and lower limb connections. To permit patients to walk at will, this robot allows walking velocity updates for various terrain types by estimating the interaction torques between the human and the upper limb device, and synchronizing the lower limb device with the upper limb device. In addition, the patient is able to navigate in VEs by generating turning commands with switches located in the handles of the upper limb device. Experimental results using a healthy subject show that the user can update the walking velocity on level ground, slopes, and stairs through upper and lower limb connections. In addition, the user could navigate in the VEs with walking velocity updates and turning input command allowing various rehabilitation training modes. During a pilot clinical test, a hemiplegic patient could use the suggested gait rehabilitation robot with a slow walking speed. The rehabilitation plan was also suggested for the patient and the possible therapeutic effects of the suggested rehabilitation robot system are discussed.

3 May 2017 in Nanoscale
Verified
Journal Article
Closed access
PDF file
FAFaiz Ul Amin
Faiz Ul Amin
AHAli Kafash hoshiar
Ali Kafash hoshiar
TDTon Duc Do
Ton Duc Do
YNYeongil Noh
Yeongil Noh
SSShahid Ali Shah
Shahid Ali Shah
MKMyeng Ok Kim
Myeng Ok Kim
Alzheimer's disease (AD) is the most prevalent age-related neurodegenerative disease, pathologically characterized by the accumulation of aggregated amyloid beta (Aβ) in the brain. Here, we describe for the first time the development of a new, pioneering nanotechnology-based drug delivery approach for potential therapies for neurodegenerative diseases, particularly AD. We demonstrated the delivery of fluorescent carboxyl magnetic Nile Red particles (FMNPs) to the brains of normal mice using a functionalized magnetic field (FMF) composed of positive- and negative-pulsed magnetic fields generated by electromagnetic coils. The FMNPs successfully reached the brain in a few minutes and showed evidence of blood–brain barrier (BBB) crossing. Moreover, the best FMF conditions were found for inducing the FMNPs to reach the cortex and hippocampus regions. Under the same FMF conditions, dextran-coated Fe3O4 magnetic nanoparticles (MNPs) loaded with osmotin (OMNP) were transported to the brains of Aβ1–42-treated mice. Compared with native osmotin, the OMNP potently attenuates Aβ1–42-induced synaptic deficits, Aβ accumulation, BACE-1 expression and tau hyperphosphorylation. This magnetic drug delivery approach can be extended to preclinical and clinical use and may advance the chances of success in the treatment of neurological disorders like AD in the future.

26 September 2006 in Journal of Robotic Systems
Verified
Journal Article
Closed access
PDF file
JYJungwon Yoon
Jungwon Yoon
Jeha RyuJeha Ryu
Jeha Ryu
KLKil‐Byung Lim
Kil‐Byung Lim

1 September 2001 in IEEE/ASME Transactions on Mechatronics
Verified
Journal Article
Closed access
JYJungwon Yoon
Jungwon Yoon
JRJeha Ryu
Jeha Ryu
This paper presents design, fabrication, and evaluation of a new 6-DOF haptic device for interfacing with virtual reality by using a parallel mechanism. The mechanism is composed of three pantograph mechanisms that are driven by ground-fixed servomotors, three spherical joints between the top of the pantograph mechanisms and the connecting bars, and three revolute joints between the connecting bars and a mobile joystick handle. Forward and inverse kinematic analyses are performed and the Jacobian matrix is derived. Performance indexes such as global payload index, global conditioning index, translation and orientation workspaces, and sensitivity are evaluated to find optimal parameters in the design stage. The proposed haptic mechanism has better load capability than those of the pre-existing haptic mechanisms due to the fact that the motors are fixed at the base. It has also a wider orientation workspace mainly due to a RRR-type spherical joint. A control method is presented with gravity compensation and force feedback by a force/torque sensor to compensate for the effects of unmodeled dynamics such as friction and inertia. Also, the dynamic performance is evaluated for force characteristics. Virtual wall simulation with the developed haptic device is demonstrated.